Henrik Imberg

697 total citations
49 papers, 437 citations indexed

About

Henrik Imberg is a scholar working on Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Henrik Imberg has authored 49 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Obstetrics and Gynecology and 7 papers in Surgery. Recurrent topics in Henrik Imberg's work include Diabetes Management and Research (14 papers), Diabetes Treatment and Management (11 papers) and Pregnancy and preeclampsia studies (8 papers). Henrik Imberg is often cited by papers focused on Diabetes Management and Research (14 papers), Diabetes Treatment and Management (11 papers) and Pregnancy and preeclampsia studies (8 papers). Henrik Imberg collaborates with scholars based in Sweden, United States and Australia. Henrik Imberg's co-authors include Marcus Lind, Olle Nerman, Rury R. Holman, Ruth L. Coleman, Sofia Dahlqvist, Irl B. Hirsch, Henrik Zetterberg, Markus Axelsson, Lenka Novakova and Clas Malmeström and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Diabetes Care.

In The Last Decade

Henrik Imberg

37 papers receiving 430 citations

Peers

Henrik Imberg

EDM

SURGE

GENET

PFM

Alexander Shinkov Bulgaria

Amal Shibli‐Rahhal United States

Preneet Cheema Brar United States

S. H. P. P. Roerink Netherlands

Angela Ida Pincelli Italy

Sorina Martin Romania

P. Chanson France

Roberto Franceschi Italy

Francesca Marciello Italy

Ahmet Kaya Türkiye

Alexander Shinkov Bulgaria

Henrik Imberg

206 ×0.8

EDM

72 ×0.8

SURGE

54 ×0.8

32 ×0.5

GENET

76 ×2.4

PFM

Citations per year, relative to Henrik Imberg Henrik Imberg (= 1×) peers Alexander Shinkov

Countries citing papers authored by Henrik Imberg

Since Specialization

Citations

This map shows the geographic impact of Henrik Imberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Imberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Imberg more than expected).

Fields of papers citing papers by Henrik Imberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Imberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Imberg. The network helps show where Henrik Imberg may publish in the future.

Co-authorship network of co-authors of Henrik Imberg

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Imberg. A scholar is included among the top collaborators of Henrik Imberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Imberg. Henrik Imberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Imberg, Henrik, et al.. (2025). Advancing a machine learning-based decision support tool for pre-hospital assessment of dyspnoea by emergency medical service clinicians: a retrospective observational study. BMC Emergency Medicine. 25(1). 2–2. 1 indexed citations

Cluver, Catherine, Eric Decloedt, Lucy Brink, et al.. (2025). Safety and potential efficacy of DM199, a tissue kallikrein-1 analogue, for treating pre-eclampsia and fetal growth restriction: study protocol for a South African, hospital-based phase I/II open-label trial. BMJ Open. 15(12). e104035–e104035.

Imberg, Henrik, et al.. (2025). Evaluating the Adequacy of Coefficient of Variation and Standard Deviation as Metrics of Glucose Variability in Type 1 Diabetes Based on Data from the GOLD and SILVER Trials. Diabetes Technology & Therapeutics. 27(8). 606–612.

Michelsen, Jens, et al.. (2025). Remote monitoring of cystic fibrosis lung disease in children and young adults. Journal of Cystic Fibrosis. 24(4). 704–709.

Holmer, Jacob, et al.. (2025). Tooth Loss in Individuals with Dementia: A Swedish Register-Based Cohort Study. Journal of Dental Research. 105(1). 149–155.

Ludvigsson, Johnny, Staffan Mårild, Henrik Imberg, et al.. (2025). Early-Life Body Mass Index and Inflammatory Bowel Disease Risk: A Scandinavian Birth Cohort Study. Inflammatory Bowel Diseases. 31(12). 3327–3336.

Imberg, Henrik, et al.. (2024). Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes. Journal of Diabetes Science and Technology. 19(6). 1598–1607. 7 indexed citations

Imberg, Henrik, Irl B. Hirsch, Erik Schwarcz, et al.. (2024). Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia. 67(8). 1517–1526. 8 indexed citations

Imberg, Henrik, et al.. (2024). Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study. Pediatric Pulmonology. 59(11). 2967–2975. 4 indexed citations

10.

Cluver, Catherine, Lina Bergman, Henrik Imberg, et al.. (2024). Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial. BMJ Open. 14(6). e082880–e082880. 3 indexed citations

11.

Imberg, Henrik, et al.. (2024). Active Sampling: A Machine-Learning-Assisted Framework for Finite Population Inference with Optimal Subsamples. Technometrics. 67(1). 46–57.

12.

Ólafsdóttir, Arndís F., et al.. (2023). The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover trial. The Lancet Regional Health - Europe. 37. 100799–100799. 4 indexed citations

13.

Cluver, Catherine, Lina Bergman, Johanna Bergkvist, et al.. (2023). Impact of fetal growth restriction on pregnancy outcome in women undergoing expectant management for preterm pre‐eclampsia. Ultrasound in Obstetrics and Gynecology. 62(5). 660–667. 4 indexed citations

14.

Bergman, Lina, Roxanne Hastie, Henrik Zetterberg, et al.. (2022). Cerebral biomarkers in neurologic complications of preeclampsia. American Journal of Obstetrics and Gynecology. 227(2). 298.e1–298.e10. 14 indexed citations

15.

Lind, Marcus, Henrik Imberg, Ruth L. Coleman, Olle Nerman, & Rury R. Holman. (2021). Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88. Diabetes Care. 44(10). 2231–2237. 75 indexed citations

16.

Imberg, Henrik, Vera Lisovskaja, Selpi Selpi, & Olle Nerman. (2021). Optimization of Two-Phase Sampling Designs With Application to Naturalistic Driving Studies. IEEE Transactions on Intelligent Transportation Systems. 23(4). 3575–3588. 1 indexed citations

17.

Ytreberg, Erik, Ida‐Maja Hassellöv, Kent Salo, et al.. (2021). Effects of seawater scrubbing on a microplanktonic community during a summer-bloom in the Baltic Sea. Environmental Pollution. 291. 118251–118251. 12 indexed citations

18.

Imberg, Henrik, et al.. (2020). Optimal sampling in unbiased active learning. Chalmers Research (Chalmers University of Technology). 108. 559–569.

19.

Novakova, Lenka, Markus Axelsson, Clas Malmeström, et al.. (2018). Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers. PLoS ONE. 13(4). e0194828–e0194828. 41 indexed citations

20.

Filipsson, Karin, Henrik Imberg, Stefan Sjöberg, et al.. (2018). Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI‐liraglutide study 5). Obesity Science & Practice. 5(2). 130–140. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact